Juan Zhou

6PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 01, 2023
Residual plasma Epstein-Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma.

Ping Zhou, Juan Zhou, Chen-Lu Lian

|May 26, 2021
circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade.

San-Gang Wu, Ping Zhou, Jian-Xian Chen

|Nov 17, 2020
Analysis of the Trends in Publications on Clinical Cancer Research in Mainland China from the Surveillance, Epidemiology, and End Results (SEER) Database: Bibliometric Study.

Min-Qiang Lin, Chen-Lu Lian, Ping Zhou

|Sep 23, 2020
Incorporation of biologic factors for the staging of de novo stage IV breast cancer.

Zhen-Yu He, Chen-Lu Lian, Jun Wang

|Aug 17, 2018
Survival benefits with the addition of adjuvant hysterectomy to radiochemotherapy for treatment of stage I-II adenocarcinoma of the uterine cervix.

Xiao-Bin Huang, Wen-Wen Zhang, San-Gang Wu

|Oct 14, 2017
Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.

San Gang Wu, Jia Yuan Sun, Zhen Yu He

Pageof 1

Frequent Collaborators

2 joint publications

San-Gang Wu

1 joint publications

San Gang Wu

1 joint publications

Jia Yuan Sun

1 joint publications

Zhen Yu He